SS
BOLD

SBI Securities’s Boundless Bio BOLD Stock Holding History

SBI Securities’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Buy
+1
New +$1 ﹤0.01% 4002

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

SBI Securities's BOLD Position: Q1 2026 in Review

SBI Securities opened a new position in Boundless Bio (BOLD) in Q1 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #4002 among its holdings.

36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

  • SBI Securities held 1 share of Boundless Bio worth $1 as of Q1 2026.
  • Boundless Bio was a new SBI Securities position in Q1 2026.
  • Boundless Bio made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #4002 holding.
  • 36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.